TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nobel Biocare AB
Closing information (x1000 SEK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
563,609
|
492,140
|
359,168 |
| Financial expenses |
28,584
|
16,826
|
4,468 |
| Earnings before taxes |
34,131
|
12,495
|
4,434 |
| EBITDA |
100,999
|
55,192
|
31,142 |
| Total assets |
1,419,577
|
2,327,270
|
0 |
| Current assets |
384,115
|
1,284,187
|
782,998 |
| Current liabilities |
212,667
|
1,146,770
|
610,879 |
| Equity capital |
1,193,538
|
1,167,049
|
1,156,515 |
| - share capital |
317,186
|
317,186
|
317,186 |
| Employees (average) |
364
|
350
|
296 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
84.1%
|
50.1% | |
| Turnover per employee |
1,548
|
1,406
|
1,213 |
| Profit as a percentage of turnover |
6.1%
|
2.5%
|
1.2% |
| Return on assets (ROA) |
4.4%
|
1.3% | |
| Current ratio |
180.6%
|
112.0%
|
128.2% |
| Return on equity (ROE) |
2.9%
|
1.1%
|
0.4% |
| Change turnover |
71,469
|
132,972
|
-32,968 |
| Change turnover % |
15%
|
37%
|
-8% |
| Chg. No. of employees |
14
|
54
|
3 |
| Chg. No. of employees % |
4%
|
18%
|
1% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.